Effect of LY450139 on the Long Term Progression of Alzheimer's Disease
- Conditions
- Health Condition 1: G309- Alzheimers disease, unspecified
- Registration Number
- CTRI/2009/091/000090
- Lead Sponsor
- Eli Lilly and Company India Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Meets criteria for mild to moderate AD with Mini-Mental State Examination score of 16 through 26 at visit 1
-Modified Hachinski Ischemia Scale score of less than or equal to 4
-Geriatric Depression Scale score of less than or equal to 6
-A magnetic resonance imaging (MRI) or computerized tomography (CT)scan in the last 2 years with no findings inconsistent with a diagnosis of Alzheimer's disease
-If female must be without menstruation for at least 12 consecutive months or have had both ovaries removed.
-Is not capable of swallowing whole oral medication
-Has serious or unstable illnesses
-Does not have a reliable caregiver
-Chronic alcohol or drug abuse within the past 5 years
-Has ever had active vaccination for AD
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method